IMP&C is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about IMP&C. IMP&C company has started its activity in January 2019. Vision of the company is to support polish health sector to develop medical cannabis use for patients. IMP&C is acting as the exclusive importer, seller and distributor of Bazelet Group’s products in Poland. Both parties bring extensive experience in cannabis market operations and pharmaceutical distribution in Poland and Europe.
Company size
1-10 employees
Headquarters
Warsaw, Mazowieckie